免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

CARTO™ 3 EP導航系統軟體 V8.0 (FG-5400-00, FG-5400-00U)

K 號:K231207 · 2023-09-07

決定日期2023-09-07
產品代碼DQK
諮詢委員會履歷
決定相當於

器材摘要

CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00, FG-5400-00U) is the device name listed in this FDA 510(k) record. The listed applicant is Biosense Webster, Inc.. It received FDA 510(k) clearance on 2023-09-07 under 510(k) number K231207. The device is classified under product code DQK. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00, FG-5400-00U)?

CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00, FG-5400-00U) is a medical device that received FDA 510(k) clearance on 2023-09-07. The listed applicant is Biosense Webster, Inc.. The 510(k) number is K231207.

When did CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00, FG-5400-00U) receive FDA 510(k) clearance?

CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00, FG-5400-00U) received FDA 510(k) clearance on 2023-09-07, under 510(k) number K231207.

Who is the listed applicant for CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00, FG-5400-00U)?

The FDA 510(k) record lists Biosense Webster, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00, FG-5400-00U)?

The FDA product code for CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00, FG-5400-00U) is DQK.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Biosense Webster, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 25 項裝置 →

相關器械(代碼:DQK)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑